Petri Dish: C4’s deal with Merck KGaA; Boston and California biotechs merge

This week brought new partnerships, mergers and CEOs to Greater Boston’s biotech scene. Check out the latest news involving C4 Therapeutics, Merck KGaA, Akari Therapeutics and more.